Clinical features of adult patients with Eisenmenger's syndrome in Japan and Korea

International Journal of Cardiology

Volumn 167, Issue 1, 2013, Pages 205-209

  Sakazaki, Hisanori ^a   Niwa, Koichiro ^b   Nakazawa, Makoto ^c   Saji, Tsutomu ^d   Nakanishi, Toshio ^e   Takamuro, Motoki ^f   Ueno, Michihiko ^g   Kato, Hitoshi ^h   Takatsuki, Shinichi ^d   Matsushima, Masaki ⁱ   Kojima, Namiko ^j   Ichida, Fukiko ^k   Kogaki, Shigetoyo ^l   Kido, Sachiko ^m   Arakaki, Yoshio ⁿ   Waki, Kenji ⁿ   Akagi, Teiji ^o   Joo, Kunitaka ^p   Muneuchi, Jun ^p   Suda, Kenji ^q   Lee, Heung Jae ^r   Shintaku, Haruo ^s   more..

^a Hyogo Prefectural Amagasaki Hospital   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c Southern Tohoku General Hospital   (Japan)

^d TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f SAPPORO MEDICAL UNIVERSITY   (Japan)

^g HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^h National Center for Child Health   (Japan)

ⁱ CHUKYO HOSPITAL   (Japan)

^j Meijou Hosipital ^*  (Japan)

^k TOYAMA UNIVERSITY HOSPITAL   (Japan)

^l OSAKA UNIVERSITY HOSPITAL   (Japan)

^m KOBE CHILDREN S HOSPITAL   (Japan)

ⁿ KURASHIKI CENTRAL HOSPITAL   (Japan)

^o OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^p KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

^q KURUME UNIVERSITY HOSPITAL   (Japan)

^r Samsung Medical Center   (South Korea)

^s OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Congenital heart disease; Eisenmenger's syndrome; Hypoxemia; Pulmonary hypertension; Pulmonary vasodilator

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BERAPROST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; OXYGEN; PIMOBENDAN; POTASSIUM SPARING DIURETIC AGENT; PROSTACYCLIN; SILDENAFIL; SPIRONOLACTONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVERSION; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EISENMENGER COMPLEX; FEMALE; FOLLOW UP; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HEMATOCRIT; HUMAN; JAPAN; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OXYGEN SATURATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUDDEN DEATH; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; EISENMENGER COMPLEX; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84878593007     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.12.030     Document Type: Article

References (26)

1. N. Galie, M. Beghetti, and M.A. Gatzoulis Bosentan therapy in patients with Eisenmenger syndrome. A multicenter, double-blind, randomized, placebo-controlled study Circulation 114 2006 48 54
2. M.A. Gatzoulis, M. Beghetti, and N. Galie Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study Int J Cardiol 127 2007 27 32
3. T.P. Singh, M. Rohit, A. Grover, S. Malhotra, and R. Vijavergiya A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension Am Heart J 151 2006 851.e1 851.e5
4. E.M.C. Chau, K.Y.Y. Fan, and W.H. Chow Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary artery hypertension Int J Cardiol 120 2007 301 305
5. K. Dimopoulos, R. Inuzuka, and M.A. Gatzoulis Improved survival among patients with eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension Circulation 121 2010 20 25
6. A. Saha, K.G. Balakrishnan, and P.K. Jaiswal Prognosis for patients with Eisenmenger syndrome of various aetiology Int J Cardiol 45 1994 199 207
7. L. Daliento, J. Somerville, and P. Presbitero Eisenmenger syndrome. Factors relating to deterioration and death Eur Heart J 19 1998 1845 1855
8. K. Niwa, J.K. Perloff, and S. Kaplan Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart J Am Coll Cardiol 34 1999 223 232
9. W.J. Cantor, D.A. Harrison, and J.S. Moussadji Determinants of survival and length of survival in adults with Eisenmenger syndrome Am J Cardiol 84 1999 677 681
10. H. Oya, N. Nagaya, and K. Miyatake Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome Heart 84 2000 53 58
11. H. Oya, N. Nagaya, and K. Miyatake Poor prognosis and related factors in adults with Eisenmenger syndrome Am Heart J 143 2002 739 744
12. G.P. Diller, K. Dimopoulos, and M.A. Gatzoulis Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study Eur Heart J 27 2006 1737 1742
13. P. Wood The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt BMJ 46 1958 755 762
14. N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
15. W.A. Zoghbi, M. Enriquez-Sarano, and E. Foster Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802
16. J. Tongers, B. Schwerdtfeger, and G. Klein Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension Am Heart J 153 2007 127 132
17. C.S. Broberg, M. Ujita, and M.A. Gatzoulis Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity J Am Coll Cardiol 50 2007 634 642
18. C.K. Silversides, J.T. Granton, E. Konen, M.A. Hart, G.D. Webb, and J. Therrien Pulmonary thrombosis in adults with Eisenmenger syndrome J Am Coll Cardiol 42 2003 1982 1987
19. J.K. Perloff, E.M. Hart, S.M. Greaves, P.D. Miner, and J.S. Child Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension Am J Cardiol 92 2003 182 187
20. C.R. Keenan, and R.H. Whilte The effect of race/ethnicity and sex on the risk of venous thromboembolism Curr Opin Pulm Med 13 2007 377 383
21. N. Galie, M. Humbert, and J.L. Vachiery Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomised, double-blind placebo-controlled trial J Am Coll Cardiol 39 2002 1496 1502
22. R.J. Barst, M. McGoon, and V.V. Mc Laughlin Beraprost therapy for pulmonary arterial hypertension J Am Coll Cardiol 41 12 2003 Jun 18 2119 2125
23. E.L. Tay, M. Papaphylactou, and M.A. Gatzoulis Quality of life and functional capacity can be improved in patients with Eisenmenger syndrome with oral sildenafil therapy Int J Cardiol 149 3 2011 Jun 16 372 376
24. K. Iversen, A.S. Jensen, T.V. Jensen, N.G. Vejlstrup, and L. Søndergaard Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial Eur Heart J 31 2010 1124 1131
25. M. D'Alto, E. Romeo, and P. Argiento Bosetan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology Int J Cardiol 155 3 2012 Mar 22 378 382
26. K. Dimopoulos, G.P. Diller, and M.A. Gatzoulis Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease Circulation 117 2008 2320 2328